Chronic hepatitis C in the hispanic/latino population living in the United States: A literature review

Gastroenterology Nursing

Volumn 31, Issue 1, 2008, Pages 17-25

  Blessman, Donna Jean ^a,b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

AIDS RELATED COMPLEX; BLOOD; BLOOD TRANSFUSION; CULTURAL COMPETENCE; DEMOGRAPHY; DISEASE COURSE; ETHNOLOGY; HEPATITIS C; HISPANIC; HUMAN; MASS SCREENING; METABOLISM; METHODOLOGY; MIGRATION; MINORITY GROUP; ONSET AGE; PREVALENCE; REVIEW; RISK FACTOR; STATISTICS; TATTOOING; TREATMENT OUTCOME; UNITED STATES;

AGE OF ONSET; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD TRANSFUSION; CULTURAL COMPETENCY; DISEASE PROGRESSION; EMIGRANTS AND IMMIGRANTS; HEPATITIS C, CHRONIC; HISPANIC AMERICANS; HUMANS; MASS SCREENING; MINORITY GROUPS; PREVALENCE; RESEARCH DESIGN; RESIDENCE CHARACTERISTICS; RISK FACTORS; TATTOOING; TREATMENT OUTCOME; UNITED STATES;

EID: 39849098259     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/01.SGA.0000310931.64854.5f     Document Type: Review

References (57)

1. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556-562.
2. Alter, M. J., Seeff, L. B., Bacon, B. R., Thomas, D. L., Rigsby, M. O., & DiBisceglie, A. M. (2004). Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Annals of Internal Medicine, 141, 715-717.
3. Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144, 705-714.
4. Balasekaran, R., Bulterys, M., Jamal, M., Quinn, P., Johnston, D., Skipper, B., Chaturvedi, S., & Arora, S. (1999). A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. American Journal of Gastroenterology, 94, 1341-1346.
5. Betancourt, J. R. (2006). Cultural competence and medical education: Many names, many perspectives, one goal [Electronic version]. Academic Medicine, 81, 499-501.
6. Bonacini, M., Groshen, S., Yu, M. C., Govindarajan, S., & Lindsay, K. L. (2001). Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. American Journal of Gastroenterology, 96, 2438-2441.
7. Celona, A. F., Yu, M. C., Prakash, M., Kuo, T., & Bonacini, M. (2004). Hepatitis C in a Los Angeles public health clinic: Demographic and biochemical differences associated with race-ethnicity. Clinical Gastroenterology & Hepatology, 2, 459-462.
8. Centers for Disease Control and Prevention. (2003). Hepatitis C. Retrieved February 16, 2006, from http://www.cdc.gov/ ncidod/diseases/hepatitis/ slideset/hep_c/hcv_epi_for_distrib_000925.ppt
9. Cheung, R. C., Currie, S., Shen, H., Ho, S. B., Bini, E. J., Anand, B. S., et al. (2005). Chronic hepatitis C in Latinos: Natural history, treatment eligibility, acceptance, and outcomes. American Journal of Gastroenterology, 100, 2189-2193.
10. Chou, R., Clark, E. C., & Helfand, M. (2004). Screening for hepatitis C virus infection: A review of the evidence for the U.S. Preventive Services Task Force [Electronic version]. Annals of Internal Medicine, 140, 465-483.
11. Clark, E. C., Yawn, B. P., Galliher, J. M., Temte, J. L., & Hickner, J. H. (2005). Hepatitis C identification and management by family physicians. Family Medicine, 37, 644-649.
12. Dev, A., Sundararajan, V., & Sievert, W. (2004). Ethnic and cultural determinants influence risk assessment for hepatitis C acquisition. Hepatology, 19, 792-798.
13. DiBisceglie, A. (2002). National Institutes of Health consensus development conference statement 2002: Optimal therapy of hepatitis C. Retrieved June 10, 2005, from http://consensus.nih.gov/2002/2002HepatitisC 2002116html.htm
14. Estrada, A. L. (2005). Health disparities among African American and Hispanic drug injectors - HIV, AIDS, hepatitis B virus and hepatitis C virus: A review [Electronic version]. AIDS, 19, S47-S52.
15. Focaccia, R., Baraldo, D., Ferraz, M., Martinelli, A., Carrilho, F., Goncales. F., et al. (2004). Demographic and anthropometrical analysis and genotype distribution of chronic hepatitis C patients treated in public and private reference centers in Brazil [Electronic version]. The Brazilian Journal of Infectious Diseases, 8, 348-355.
16. Frank, C., Mohamed, M., Strickland, G., Lavanchy, D., Athur, R., Magder, L., et al. (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355, 887-891.
17. Fry, C. L., & Lintzeris, N. (2003). Psychometric properties of the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction, 98, 171-178.
18. Haley, R. W., & Fischer, R. P. (2001). Commercial tattooing as a potentially important source of hepatitis C infection: Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine, 80, 134-151.
19. Hand, W. L., & Vasquez, Y. (2005). Risk factors for hepatitis C on the Texas-Mexico border. American Journal of Gastroenterology, 100, 2180-2185.
20. Hepburn, M., Hepburn, L., Cantu, N., Lapeer, M., & Lawitz, E. (2004). Differences in treatment outcome for hepatitis C among ethnic groups. American Journal of Medicine, 117, 163-168.
21. Hezode, C., Roudot Thoraval, F., Nguyen, S., Grenard, P., Julien, B., Zafrani, E., et al. (2005). Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology, 41, 63-71.
22. Joveleviths, D., Fujii, L., Marques, G., Merlo, A., Fabris, P., & Trindade, D. (2006). Hepatitis C in former soccer players from 1950 to 1980 [Abstract]. Journal of Clinical Virology, 36, S150-S151. Retrieved January 14, 2007, from http://www.isvhld2006.com/
23. Leigh, J. P., Bowlus, C. L., Leistikow, B. N., & Schenker, M. (2001). Costs of hepatitis C. [Electronic version]. Archives of Internal Medicine, 161, 2231-2237.
24. Lepe, R., Layden-Almer, J. E., Layden, T. J., & Cotler, S. (2006). Ethnic differences in the presentation of chronic hepatitis C. Journal of Viral Hepatitis, 13, 116-120.
25. Marín y López, R. A., Romero-Estrella, S., Infante-Ramírez, L., Ménde-Aquino, J. S., Berrón-Ruiz, P., Morales-Alfaro, N. A., et al. (2004). Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form. Transfusion, 44, 1344-1349.
26. Meleis, A. (1996). Culturally competent scholarship: Substance and rigor. Advances in Nursing Science, 19, 1-16.
27. Memon, M. I., & Memon, M. A. (2002). Hepatitis C: An epidemiological review. Journal of Viral Hepatitis, 9, 84-100.
28. Mendez-Sanchez, N., Ponciano-Rodriguez, G., Chavez-Tapia, N. C., Motola-Kuba, D., Almeda-Valdes, P., Sanchez-Lara, K., et al. (2005). Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico City. Digestive Diseases & Sciences, 50,733-737.
29. Montella, M., Crispo, A., Grimaldi, M., Tridente, V., & Fusco, M. (2003). Assessment of iatrogenic transmission of HCV in southern Italy: Was the cause the Salk polio vaccination? Journal of Medical Virology, 70, 49-50.
30. National Institutes of Health. (2002). Consensus development conference statement management of hepatitis C:2002. Retrieved June 10, 2005, from http://consensus.nih.gov/ 2002/2002HepatitisC2002116html.htm
31. National Institutes of Medicine. (2002). Unequal treatment: What healthcare providers need to know about racial and ethnic disparities in healthcare. Retrieved January 15, 2006, from http://www.iom.edu/Object.File/ Master/4/175/ Disparitieshcproviders8pgFINAL.pdf
32. Navarro, V. J., St. Louis, T. E., & Bell, B. P. (2003). Identification of patients with hepatitis C virus infection in New Haven county primary care practices. Journal of Clinical Gastroenterology, 36, 431-435.
33. Nguyen, M. T., Herrine, S. K., Laine, C. A., Ruth, K., & Weinberg, D. S. (2005). Description of a new hepatitis C risk assessment tool. Archives of Internal Medicine, 165, 2013-2018.
34. Pew Hispanic Center. (2004, March). Healthcare experiences. Retrieved May 6, 2006, from http://64.233.167.104/u/ pewhispanic?q=cache: 5eqiW_DxaMJ:pewhispanic.org/ files/factsheets/14.pdf+healthcare&hl= en&ct=clnk&cd= 1&gl=us&ie=UTF-8
35. Pew Hispanic Center. (2005, January). Hispanics: A people in motion. Retrieved May 6, 2006, from http://pewresearch. org/assets/files/ trends2005-hispanic.pdf
36. Pyrsopoulos, N., & Jeffers, L. (2007). Hepatitis C in African Americans [Electronic version]. Journal of Clinical Gastroenterology, 41, 185-193.
37. Rawls, R. A., & Vega, J. (2005). Viral hepatitis in minority America. Journal of Clinical Gastroenterology, 39, 144-151.
38. Reddy, R. K., Hoofnagle, J. H., Tong, M. J., Lee, W. M., Pockros, P., Heathcote, E. J., et al. (1999). Racial differences in responses to therapy with interferon in chronic hepatitis C. Hepatology, 30, 787-793.
39. Rodriguez-Torres, M., Rios-Bedoya, C. F., Rodriguez-Orengo, J., Fernandez-Carbia, A., Marxuach-Cuetara, A. M., Lopez-Torres, A., et al. (2006). Progression to cirrhosis in Latinos with chronic hepatitis C: Differences in Puerto Ricans with and without human immunodeficiency virus co-infection and along gender. Journal of Clinical Gastroenterology, 40, 358-366.
40. Sanchez, J., Sjogren, M., Callahan, J., Watts, D., Lucas, C., Abdel-Hamid, M., et al. (2000). Hepatitis C in Peru: Risk factors for infection, potential iatrogenic transmission, and genotype distribution. American Journal of Tropical Medicine & Hygiene, 63, 242-248.
41. Schmunis, G. A., Zicker, F., Cruz, J. R., & Cuchi, P. (2001). Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. American Journal of Tropical Medicine & Hygiene, 65, 924-930.
42. Seeff, L. (2002). Natural history of chronic hepatitis C. In NIH Consensus Development Conference on Management of Hepatitis C: 2002. Retrieved December 19, 2007, from www.medadvocates.org/resources/conferences/ NIHHCVConsensusConference/NIHHCVNaturalHistory.htm
43. Shehab, T. M., Sonnad, S. S., & Lok, A. S. F. (2001). Management of hepatitis C patients by primary care physicians in the USA: Results of a national survey [Electronic version]. Journal of Viral Hepatitis, 8, 377-383.
44. Shehab, T. M., Sonnad, S., Gebremariam, A., & Schoenfeld, P. (2002). Knowledge of hepatitis C screening and management by internal medicine residents: Trends over 2 years. American Journal of Gastroenterology, 97, 1216-1222.
45. Shehab, T. M., Orrego, M., Chunduri, R., & Lok, A. S. (2003). Identification and management of hepatitis C patients in primary care clinics. American Journal of Gastroenterology, 98, 639-644.
46. Spaulding, A., Weinbaum, C., Lau, D., Sterling, R., Seeff, L., Margolis, H., & Hoofnagle, J. (2006). A framework for management of hepatitis C in prisons [Electronic version]. Annals of Internal Medicine, 144, 762-769.
47. Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004). American Association for the Study of Liver Disease practice guideline: Diagnosis, management and treatment of hepatitis C. Hepatology, 39, 1147-1171.
48. Tallis, G. F., Tyan, G. M., Lambert, S. B., Bowden, D. S., McCaw, R., Birch, C. J., et al. (2003). Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules. Journal of Viral Hepatitis, 10, 234-239.
49. Teixeira-Clerc, F., Julien, B., Grenard, P., Tran Van Nhieu, J., Deveaux, V., Li, L., Serriere-Lanneau, V., et al. (2006). CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis [Electronic version]. Nature Medicine, 12, 671-676.
50. U.S. Census Bureau. (2003, June). The Hispanic population in the United States: March 2002, Population characteristics (Publication No. P20-545). Retrieved May 6, 2006, from http://www.census.gov/prod/2003pubs/p20- 545.pdf
51. U.S. Department of Health and Human Services. (2001). Hepatitis C: An emerging threat to public health. Retrieved November 15, 2006, from www.hhs.gov/news/press/2001pres/01fshepatitisC.html
52. U.S. Department of Justice, Bureau of Justice Statistics. (2005). Prison statistics summary findings. Retrieved April 4, 2006, from http://www.ojp.usdoj.gov/bjs/prisons.htm
53. Verma, S., Bonacini, M., Bovindarajan, S., Kanel, G., Lindsay, K., & Redeker, A. (2006). More advanced hepatic fibrosis in Hispanics with chronic hepatitis C infection: Role of patient demographics, hepatic necroinflammation, and steatosis [Electronic version]. American Journal of Gastroenterology, 101, 1817-1823.
54. Wong, J. B., McQuillan, G. M., McHutchison, J. G., & Poynard, T. (2000). Estimating future hepatitis C morbidity, mortality, and costs in the United States [Electronic version]. American Journal of Public Health, 90, 1562-1569.
55. World Health Organization. (1997, November 14). Weekly epidemiological record: Hepatitis C global prevalence. Retrieved November 15, 2006, from www.who.int/wer/ pdf/1997/wer7246.pdf
56. Yen, T., Keeffe, E. B., & Ahmed, A. (2003). The epidemiology of hepatitis C virus infection. Journal of Clinical Gastroenterology. 36, 47-53.
57. Yildirim, B., Tahan, V., Ozaras, R., Aytekin, H., Mert, A., Tabak, F., & Senturk, H. (2005). Hepatitis C virus risk factors in the Turkish community. Digestive Diseases & Sciences, 50, 2352-2355.